Kiniksa Pharmaceuticals

+$0.37 (+2.61%) Today
-$0.02 (-0.14%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KNSA and other ETFs, options, and stocks.

About KNSA

Kiniksa Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Its products include Rilonacept, Mavrilimumab, Vixarelimab, and KPL-404.

CEO
Sanj K. Patel
Employees
168
Headquarters
Hamilton, Hamilton
Founded
2015

KNSA Key Statistics

Market Cap
995.69M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
328.01K
High Today
$14.62
Low Today
$14.09
Open Price
$14.23
Volume
659.72K
52 Week High
$24.70
52 Week Low
$13.00

KNSA Earnings

-$0.80
-$0.53
-$0.27
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 3, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure